| Organism name | Citrus grandis |
|---|---|
| Genus | Citrus |
| Family | Rutaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Citrus maxima |
|---|---|
| Linked NCBI taxonomy ID | 37334 |
| Linked level | species |
| Family in NCBI taxonomy | Rutaceae |
|---|---|
| ID | 23513 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00004019
|
Honyucitrin
|
No. 319 | No. 15 |
|
||||
|
C00003131
|
beta-Farnesene
/ (E)-beta-Farnesene / beta-trans-Farnesene |
C062671
|
No. 404 | No. 38 |
|
|||
|
C00048367
|
Curcumene
|
CHEMBL469717
|
C086829
|
No. 456 | No. 38 |
|
||
|
C00002144
|
Buntanine
|
No. 469 | No. 7 |
|
||||
|
C00000805
|
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
|
|
C00000816
|
beta-Pinene
|
CHEMBL501351
|
C010789
|
No. 476 | No. 35 |
|
||
|
C00003110
|
Caryophyllene
/ (E)-Caryophyllene / beta-Caryophyllene / (-)-(E)-Caryophyllene / (E)-beta-Caryophyllene |
CHEMBL445740
CHEMBL448700 |
2 / 3 / 7 | No. 478 | No. 38 |
|
||
|
C00003166
|
Nerolidol
|
CHEMBL25424
CHEMBL508801 CHEMBL561014 CHEMBL1923157 |
3 / 3 / 1 | No. 726 | No. 38 |
|
||
|
C00000823
|
Limonene
|
CHEMBL15799
CHEMBL449062 |
C008281
|
7 / 21 / 48 | 6 / 6 | No. 848 | No. 35 |
|
|
C00003047
|
Linalool
/ (R)-linalool / (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol |
CHEMBL25306
CHEMBL235672 |
C018584
|
6 / 8 / 2 | 35 / 4 | No. 958 | No. 34 |
|
|
C00002503
|
Umbelliferon
/ Umbelliferone / 7-Hydroxycoumarin |
CHEMBL51628
|
C031477
|
39 / 33 / 32 | 9 / 0 | No. 1030 | No. 25 |
|
|
C00000184
|
alpha-Thujene
|
No. 1343 | No. 35 |
|
||||
|
C00031258
|
Sabinene
/ 4(10)-Thujene |
CHEMBL452687
|
C035127
|
No. 1343 | No. 35 |
|
||
|
C00000855
|
Nerol
/ cis-Geraniol |
CHEMBL25719
CHEMBL452683 |
96 / 41 / 41 | No. 1575 | No. 34 |
|
||
|
C00048310
|
Allo-Ocimene
|
C015659
|
No. 1698 | No. 34 |
|
|||
|
C00048486
|
Neo-allo-ocimene
|
No. 1698 | No. 34 |
|
||||
|
C00003040
|
p-Cymene
|
CHEMBL442915
|
C007210
|
No. 2172 | No. 35 |
|
||
|
C00048315
|
alpha-Myrcene
|
No. 2285 | No. 34 |
|
||||
|
C00000853
|
Myrcene
|
CHEMBL455491
|
C008574
|
3 / 3 / 3 | No. 2285 | No. 34 |
|
|
|
C00003060
|
alpha-Terpinene
|
No. 2468 | No. 35 |
|
||||
|
C00002074
|
Stachydrine
|
CHEMBL394450
CHEMBL1456892 CHEMBL1986864 |
10 / 8 / 12 | No. 2627 | No. 1 |
|
||
|
C00011045
|
delta-3-Carene
/ (-)-Carene(-)-3-Carene |
CHEMBL506854
|
No. 2690 | No. 35 |
|
|||
|
C00000357
|
Hexanal
|
CHEMBL280331
|
C010463
|
7 / 0 | No. 3593 |
|
||
|
C00000358
|
n-Hexanol
|
CHEMBL14085
|
C036260
|
3 / 6 / 3 | No. 3722 |
|
||
|
C00034600
|
Methyl anthranilate
|
CHEMBL1493986
|
C038892
|
3 / 3 / 3 | No. 4170 |
|
||
|
C00048248
|
(Z)-Ocimene
/ cis-Ocimene |
No. 4949 |
|
|||||
|
C00034775
|
6-Methyl-5-hepten-2-one
|
CHEMBL46340
|
C029750
|
No. 5297 |
|
|||
|
C00048304
|
Acetone
|
CHEMBL14253
|
D000096
|
1 / 11 / 10 | 10 / 8 | No. 5308 |
|
|
|
C00034989
|
(E)-Ocimene
/ trans-Ocimene |
No. 6181 |
|
|||||
|
C00048438
|
Isopropanol
|
CHEMBL582
|
D019840
|
5 / 17 / 15 | 33 / 2 | No. 6812 |
|
|
|
C00048350
|
Carvyl acetate
|
CHEMBL1351619
|
4 / 3 / 2 | No. 6846 |
|
|||
|
C00019560
|
Ethanol
|
CHEMBL545
|
D000431
|
92 / 39 / 33 | 199 / 193 | No. 8862 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000358 C00000805 C00000853 C00002074 C00019560 C00048350 | 3 / 2 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000358 C00000823 C00034600 C00048350 C00048438 | 0 / 0 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00000358 C00000823 C00003047 C00003166 C00048438 | 3 / 1 |
| O00255 | Menin | Unclassified protein | C00000855 C00002074 C00002503 C00003110 | 2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000855 C00002074 C00002503 C00003110 | 1 / 2 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002503 C00019560 C00034600 C00048438 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000823 C00000855 C00002503 C00019560 | 0 / 3 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000855 C00003047 C00003166 C00048350 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000855 C00002074 C00019560 | 1 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00000853 C00000855 C00019560 | 0 / 1 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000805 C00000855 C00019560 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000855 C00002074 C00019560 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000855 C00002074 C00019560 | 0 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000855 C00002074 C00019560 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00000855 C00002503 C00019560 | 0 / 0 |
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00019560 C00048350 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000855 C00002074 C00019560 | 0 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00000855 C00002503 C00019560 | 1 / 2 |
| P22303 | Acetylcholinesterase | Hydrolase | C00000855 C00002503 C00019560 | 1 / 0 |
| Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000855 C00002503 C00003047 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00000823 C00048304 C00048438 | 11 / 10 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000855 C00019560 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000855 C00019560 | 0 / 0 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000823 C00000855 | 0 / 0 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000855 C00019560 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000855 C00019560 | 0 / 0 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000855 C00019560 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000855 C00019560 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00000855 C00019560 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00000855 C00019560 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000855 C00019560 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000855 C00019560 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000855 C00019560 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000855 C00019560 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000855 C00019560 | 1 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000855 C00019560 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000855 C00019560 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000855 C00019560 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000855 C00019560 | 1 / 8 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000855 C00019560 | 1 / 1 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000855 C00019560 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000855 C00019560 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000855 C00019560 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000855 C00019560 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000855 C00019560 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000855 C00019560 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000855 C00019560 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000855 C00019560 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000855 C00019560 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000855 C00019560 | 1 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00000855 C00019560 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000855 C00019560 | 1 / 1 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002503 C00003047 | 5 / 1 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00000855 C00019560 | 2 / 2 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000855 C00019560 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002074 C00002503 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00000855 C00019560 | 0 / 1 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000855 C00019560 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000855 C00019560 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000855 C00019560 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000855 C00019560 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000855 C00019560 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000855 C00019560 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000855 C00019560 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000855 C00019560 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00000855 C00019560 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000855 C00019560 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000855 C00019560 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000855 C00019560 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000855 C00019560 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000855 C00019560 | 1 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000855 C00019560 | 0 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000855 C00019560 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00000855 C00019560 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000855 C00019560 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00000855 C00019560 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000855 C00019560 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002503 C00003047 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002074 C00003166 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000855 C00019560 | 0 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000855 C00019560 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000855 C00019560 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00000855 C00019560 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000855 C00019560 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000855 C00019560 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000855 C00019560 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000855 C00019560 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00000855 C00019560 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000855 C00019560 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000855 C00019560 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000855 C00019560 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000855 C00019560 | 0 / 0 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00000853 C00000855 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000855 C00019560 | 1 / 0 |
| P08246 | Neutrophil elastase | S1A | C00000855 C00019560 | 2 / 1 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000855 C00019560 | 2 / 1 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000855 C00019560 | 0 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000855 C00019560 | 2 / 2 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000855 C00019560 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002503 C00034600 | 3 / 3 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000855 C00019560 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000855 C00019560 | 0 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000855 C00019560 | 0 / 0 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002503 C00003047 | 3 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000855 C00019560 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00000855 C00019560 | 1 / 1 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000855 C00019560 | 0 / 0 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00002503 | 0 / 0 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002503 | 2 / 2 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00002503 | 0 / 1 |
| P56817 | Beta-secretase 1 | A1A | C00002503 | 0 / 0 |
| P06280 | Alpha-galactosidase A | Enzyme | C00002503 | 1 / 1 |
| P14679 | Tyrosinase | Oxidoreductase | C00002503 | 4 / 2 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00002503 | 0 / 0 |
| P15121 | Aldose reductase | Enzyme | C00002503 | 0 / 0 |
| Q00796 | Sorbitol dehydrogenase | Enzyme | C00002503 | 0 / 0 |
| P18405 | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Oxidoreductase | C00002503 | 0 / 0 |
| P55210 | Caspase-7 | C14 | C00002503 | 0 / 0 |
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002503 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00002503 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00002503 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00002503 | 1 / 2 |
| P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00002503 | 1 / 1 |
| P10275 | Androgen receptor | NR3C4 | C00048438 | 3 / 4 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00000855 | 2 / 3 |
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00000823 | 0 / 0 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002503 | 1 / 1 |
| P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002503 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002503 | 1 / 1 |
| P04062 | Glucosylceramidase | Enzyme | C00002503 | 6 / 4 |
| Q99700 | Ataxin-2 | Unclassified protein | C00002503 | 1 / 1 |
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00002503 | 1 / 1 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002503 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002503 | 1 / 1 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002503 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000823 | 7 / 37 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002503 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000823
C00002503
C00019560
|
| 2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00003047
C00019560
C00048438
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000823
C00019560
C00048438
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002503
C00019560
C00048304
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00019560
C00048304
C00048438
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000357
C00000823
C00003047
|
| 124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) |
C00019560
C00048438
|
| 217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00000357
C00019560
|
| 2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00019560
C00048438
|
| 2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00019560
C00048438
|
| 131 | ADH7, ADH4 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (EC:1.1.1.1) |
C00019560
C00048438
|
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00000357
C00003047
|
| 127 | ADH4, ADH-2 | alcohol dehydrogenase 4 (class II), pi polypeptide (EC:1.1.1.1) |
C00019560
C00048438
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00003047
C00019560
|
| 126 | ADH1C, ADH3 | alcohol dehydrogenase 1C (class I), gamma polypeptide (EC:1.1.1.1) |
C00019560
C00048438
|
| 125 | ADH1B, ADH2 | alcohol dehydrogenase 1B (class I), beta polypeptide (EC:1.1.1.1) |
C00019560
C00048438
|
| 231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000357
C00048438
|
| 4852 | NPY, PYY4 | neuropeptide Y |
C00000823
C00003047
|
| 3678 | ITGA5, CD49e, FNRA, VLA5A | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
C00019560
C00048304
|
| 2263 | FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 | fibroblast growth factor receptor 2 (EC:2.7.10.1) |
C00019560
C00048304
|
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00019560
C00048304
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00019560
C00048304
|
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00002503
C00019560
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00019560
C00048438
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003047
C00019560
|
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00003047
C00019560
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002503
C00019560
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000823
C00003047
|
| 3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00003047
C00019560
|
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00002503
C00048438
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00003047
C00019560
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003047
C00048438
|
| 6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00019560
|
| 3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00003047
|
| 3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00003047
|
| 3308 | HSPA4, APG-2, HS24/P52, HSPH2, RY, hsp70, hsp70RY | heat shock 70kDa protein 4 |
C00003047
|
| 8850 | KAT2B, CAF, P, P/CAF, PCAF | K(lysine) acetyltransferase 2B (EC:2.3.1.48) |
C00003047
|
| 4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00003047
|
| 3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00003047
|
| 100124292 |
C00003047
|
||
| 7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00003047
|
| 7471 | WNT1, BMND16, INT1, OI15 | wingless-type MMTV integration site family, member 1 |
C00003047
|
| 26118 | WSB1, SWIP1, WSB-1 | WD repeat and SOCS box containing 1 |
C00003047
|
| 3297 | HSF1, HSTF1 | heat shock transcription factor 1 |
C00003047
|
| 8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) |
C00002503
|
| 1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00003047
|
| 1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00003047
|
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002503
|
| 1509 | CTSD, CLN10, CPSD | cathepsin D (EC:3.4.23.5) |
C00003047
|
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002503
|
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00002503
|
| 1447 | CSN2, CASB | casein beta |
C00003047
|
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00048304
|
| 1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00003047
|
| 1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00003047
|
| 3596 | IL13, IL-13, P600 | interleukin 13 |
C00048304
|
| 3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00048304
|
| 3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00048304
|
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003047
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003047
|
| 23536 | ADAT1, HADAT1 | adenosine deaminase, tRNA-specific 1 (EC:3.5.4.34) |
C00019560
|
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00003047
|
| 329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00003047
|
| 1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00003047
|
| 1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00003047
|
| 128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00019560
|
| 501 | ALDH7A1, ATQ1, EPD, PDE | aldehyde dehydrogenase 7 family, member A1 (EC:1.2.1.3 1.2.1.8 1.2.1.31) |
C00000357
|
| 22977 | AKR7A3, AFAR2 | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
C00019560
|
| 273 | AMPH, AMPH1 | amphiphysin |
C00019560
|
| 162 | AP1B1, ADTB1, AP105A, BAM22, CLAPB2 | adaptor-related protein complex 1, beta 1 subunit |
C00019560
|
| 79065 | ATG9A, APG9L1, MGD3208, mATG9 | autophagy related 9A |
C00019560
|
| 506 | ATP5B, ATPMB, ATPSB | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14) |
C00019560
|
| 8678 | BECN1, ATG6, VPS30, beclin1 | beclin 1, autophagy related |
C00019560
|
| 274 | BIN1, AMPH2, AMPHL, SH3P9 | bridging integrator 1 |
C00019560
|
| 708 | C1QBP, GC1QBP, HABP1, SF2p32, gC1Q-R, gC1qR, p32 | complement component 1, q subcomponent binding protein |
C00019560
|
| 832 | CAPZB, CAPB, CAPPB, CAPZ | capping protein (actin filament) muscle Z-line, beta |
C00019560
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00019560
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00019560
|
| 857 | CAV1, BSCL3, CGL3, MSTP085, PPH3, VIP21, CAV | caveolin 1, caveolae protein, 22kDa |
C00019560
|
| 83446 | CCDC70 | coiled-coil domain containing 70 |
C00019560
|
| 54535 | CCHCR1, C6orf18, HCR, SBP | coiled-coil alpha-helical rod protein 1 |
C00019560
|
| 894 | CCND2, KIAK0002 | cyclin D2 |
C00019560
|
| 994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) |
C00019560
|
| 55664 | CDC37L1, CDC37B, HARC | cell division cycle 37-like 1 |
C00019560
|
| 1003 | CDH5, 7B4, CD144 | cadherin 5, type 2 (vascular endothelium) |
C00019560
|
| 23552 | CDK20, CCRK, CDCH, P42, PNQALRE | cyclin-dependent kinase 20 (EC:2.7.11.22) |
C00019560
|
| 1050 | CEBPA, C/EBP-alpha, CEBP | CCAAT/enhancer binding protein (C/EBP), alpha |
C00019560
|
| 55165 | CEP55, C10orf3, CT111, URCC6 | centrosomal protein 55kDa |
C00019560
|
| 1066 | CES1, ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1 | carboxylesterase 1 (EC:3.1.1.1 3.1.1.56) |
C00019560
|
| 1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00019560
|
| 1140 | CHRNB1, ACHRB, CHRNB, CMS1D, CMS2A, SCCMS | cholinergic receptor, nicotinic, beta 1 (muscle) |
C00019560
|
| 1191 | CLU, APO-J, APOJ, CLI, CLU1, CLU2, KUB1, NA1/NA2, SGP-2, SGP2, SP-40, TRPM-2, TRPM2 | clusterin |
C00019560
|
| 1266 | CNN3 | calponin 3, acidic |
C00019560
|
| 1278 | COL1A2, OI4 | collagen, type I, alpha 2 |
C00019560
|
| 1417 | CRYBB3, CATCN2, CRYB3, CTRCT22 | crystallin, beta B3 |
C00019560
|
| 1442 | CSH1, CS-1, CSA, CSMT, PL, hCS-A | chorionic somatomammotropin hormone 1 (placental lactogen) |
C00019560
|
| 1535 | CYBA, p22-PHOX | cytochrome b-245, alpha polypeptide |
C00019560
|
| 1536 | CYBB, AMCBX2, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX | cytochrome b-245, beta polypeptide |
C00019560
|
| 54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00019560
|
| 10591 | DNPH1, C6orf108, RCL, RP3-330M21.3, dJ330M21.3 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
C00019560
|
| 1837 | DTNA, D18S892E, DRP3, DTN, DTN-A, LVNC1 | dystrobrevin, alpha |
C00019560
|
| 338599 | DUPD1, DUSP27, FMDSP | dual specificity phosphatase and pro isomerase domain containing 1 (EC:3.1.3.16 3.1.3.48) |
C00019560
|
| 2023 | ENO1, ENO1L1, MPB1, NNE, PPH | enolase 1, (alpha) (EC:4.2.1.11) |
C00019560
|
| 10961 | ERP29, C12orf8, ERp28, ERp31, PDI-DB, PDIA9 | endoplasmic reticulum protein 29 |
C00019560
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00019560
|
| 2177 | FANCD2, FA-D2, FA4, FACD, FAD, FAD2, FANCD | Fanconi anemia, complementation group D2 |
C00019560
|
| 84261 | FBXW9, Fbw9 | F-box and WD repeat domain containing 9 |
C00019560
|
| 2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00019560
|
| 221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000357
|
| 2526 | FUT4, CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX, SSEA-1 | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) (EC:2.4.1.-) |
C00019560
|
| 2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00019560
|
| 2670 | GFAP | glial fibrillary acidic protein |
C00019560
|
| 218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00000357
|
| 51031 | GLOD4, C17orf25, HC71 | glyoxalase domain containing 4 |
C00019560
|
| 2741 | GLRA1, HKPX1, STHE | glycine receptor, alpha 1 |
C00019560
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00019560
|
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00019560
|
| 2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00019560
|
| 57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide |
C00019560
|
| 1839 | HBEGF, DTR, DTS, DTSF, HEGFL | heparin-binding EGF-like growth factor |
C00019560
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00019560
|
| 3181 | HNRNPA2B1, HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2, RNPA2, SNRPB1 | heterogeneous nuclear ribonucleoprotein A2/B1 |
C00019560
|
| 3190 | HNRNPK, CSBP, HNRPK, TUNP | heterogeneous nuclear ribonucleoprotein K |
C00019560
|
| 3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00019560
|
| 9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00019560
|
| 27429 | HTRA2, OMI, PARK13, PRSS25 | HtrA serine peptidase 2 (EC:3.4.21.108) |
C00019560
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00019560
|
| 3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00019560
|
| 3486 | IGFBP3, BP-53, IBP3 | insulin-like growth factor binding protein 3 |
C00019560
|
| 3589 | IL11, AGIF, IL-11 | interleukin 11 |
C00019560
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00019560
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00019560
|
| 3708 | ITPR1, INSP3R1, IP3R, IP3R1, SCA15, SCA16, SCA29 | inositol 1,4,5-trisphosphate receptor, type 1 |
C00019560
|
| 83999 | KREMEN1, KREMEN, KRM1 | kringle containing transmembrane protein 1 |
C00019560
|
| 3875 | KRT18, CYK18, K18 | keratin 18 |
C00019560
|
| 3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 |
C00019560
|
| 3897 | L1CAM, CAML1, CD171, HSAS, HSAS1, MASA, MIC5, N-CAM-L1, N-CAML1, NCAM-L1, S10, SPG1 | L1 cell adhesion molecule |
C00019560
|
| 4017 | LOXL2, LOR2, WS9-14 | lysyl oxidase-like 2 (EC:1.4.3.-) |
C00019560
|
| 3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000823
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00019560
|
| 4144 | MAT2A, MATA2, MATII, SAMS2 | methionine adenosyltransferase II, alpha (EC:2.5.1.6) |
C00019560
|
| 4148 | MATN3, DIPOA, EDM5, HOA, OADIP, OS2 | matrilin 3 |
C00019560
|
| 406931 | MIR139, MIR139-3p, MIRN139 | microRNA 139 |
C00019560
|
| 406987 | MIR204, MIRN204, miRNA204 | microRNA 204 |
C00019560
|
| 100126336 | MIR208B, MIRN208B | microRNA 208b |
C00019560
|
| 407018 | MIR27A, MIR27, MIRN27A | microRNA 27a |
C00019560
|
| 442894 | MIR302B, MIRN302B | microRNA 302b |
C00019560
|
| 693120 | MIR33B, MIRN33B, hsa-mir-33b | microRNA 33b |
C00019560
|
| 407040 | MIR34A, MIRN34A, miRNA34A, mir-34 | microRNA 34a |
C00019560
|
| 442914 | MIR369, MIR369-3, MIRN369, MIRN369-3, hsa-mir-369 | microRNA 369 |
C00019560
|
| 442915 | MIR370, MIRN370, hsa-mir-370 | microRNA 370 |
C00019560
|
| 442918 | MIR373, MIRN373, hsa-mir-373, miRNA373 | microRNA 373 |
C00019560
|
| 494324 | MIR375, MIRN375, hsa-mir-375, miRNA375 | microRNA 375 |
C00019560
|
| 574451 | MIR432, MIRN432, hsa-mir-432 | microRNA 432 |
C00019560
|
| 619552 | MIR483, MIRN483, hsa-mir-483 | microRNA 483 |
C00019560
|
| 574450 | MIR493, MIRN493, hsa-mir-493 | microRNA 493 |
C00019560
|
| 574456 | MIR497, MIRN497, hsa-mir-497 | microRNA 497 |
C00019560
|
| 574472 | MIR518F, MIRN518F | microRNA 518f |
C00019560
|
| 574471 | MIR523, MIRN523, hsa-mir-523 | microRNA 523 |
C00019560
|
| 693191 | MIR606, MIRN606, hsa-mir-606 | microRNA 606 |
C00019560
|
| 724026 | MIR656, MIRN656, hsa-mir-656 | microRNA 656 |
C00019560
|
| 100126326 | MIR936, MIRN936, hsa-mir-936 | microRNA 936 |
C00019560
|
| 4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00019560
|
| 4548 | MTR, HMAG, MS, cblG | 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) |
C00019560
|
| 4595 | MUTYH, CYP2C, MYH | mutY homolog (EC:3.2.2.-) |
C00019560
|
| 4638 | MYLK, AAT7, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK | myosin light chain kinase (EC:2.7.11.18) |
C00019560
|
| 653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00019560
|
| 4688 | NCF2, NCF-2, NOXA2, P67-PHOX, P67PHOX | neutrophil cytosolic factor 2 |
C00019560
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00019560
|
| 4791 | NFKB2, H2TF1, LYT-10, LYT10, NF-kB2, p105, p52 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
C00019560
|
| 4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00019560
|
| 8996 | NOL3, ARC, FCM, MYP, NOP, NOP30 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
C00019560
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00019560
|
| 4854 | NOTCH3, CADASIL, CASIL, IMF2 | notch 3 |
C00019560
|
| 27035 | NOX1, GP91-2, MOX1, NOH-1, NOH1 | NADPH oxidase 1 |
C00019560
|
| 4897 | NRCAM | neuronal cell adhesion molecule |
C00019560
|
| 8829 | NRP1, BDCA4, CD304, NP1, NRP, VEGF165R | neuropilin 1 |
C00019560
|
| 100506658 | OCLN, BLCPMG | occludin (EC:2.1.1.67) |
C00019560
|
| 4968 | OGG1, HMMH, HOGG1, MUTM, OGH1 | 8-oxoguanine DNA glycosylase (EC:4.2.99.18) |
C00019560
|
| 4986 | OPRK1, K-OR-1, KOR, KOR-1, OPRK | opioid receptor, kappa 1 |
C00019560
|
| 4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00019560
|
| 84876 | ORAI1, CRACM1, IMD9, ORAT1, TMEM142A | ORAI calcium release-activated calcium modulator 1 |
C00019560
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00019560
|
| 5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00019560
|
| 5173 | PDYN, ADCA, PENKB, SCA23 | prodynorphin |
C00019560
|
| 5179 | PENK | proenkephalin |
C00019560
|
| 5204 | PFDN5, MM-1, MM1, PFD5 | prefoldin subunit 5 |
C00019560
|
| 25796 | PGLS, 6PGL | 6-phosphogluconolactonase (EC:3.1.1.31) |
C00019560
|
| 5245 | PHB, PHB1 | prohibitin |
C00019560
|
| 26227 | PHGDH, 3-PGDH, 3PGDH, PDG, PGAD, PGD, PGDH, SERA | phosphoglycerate dehydrogenase (EC:1.1.1.95) |
C00019560
|
| 5335 | PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1 | phospholipase C, gamma 1 (EC:3.1.4.11) |
C00019560
|
| 5352 | PLOD2, LH2, TLH | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (EC:1.14.11.4) |
C00019560
|
| 57048 | PLSCR3 | phospholipid scramblase 3 |
C00019560
|
| 5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00019560
|
| 5395 | PMS2, HNPCC4, PMS2CL, PMSL2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) |
C00019560
|
| 5426 | POLE, CRCS12, FILS, POLE1 | polymerase (DNA directed), epsilon, catalytic subunit (EC:2.7.7.7) |
C00019560
|
| 5443 | POMC, ACTH, CLIP, LPH, MSH, NPP, POC | proopiomelanocortin |
C00019560
|
| 5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 |
C00019560
|
| 5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00019560
|
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00019560
|
| 100136658 |
C00019560
|
||
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00019560
|
| 8497 | PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
C00019560
|
| 5052 | PRDX1, MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB, PRX1, PRXI, TDPX2 | peroxiredoxin 1 (EC:1.11.1.15) |
C00019560
|
| 9588 | PRDX6, 1-Cys, AOP2, NSGPx, PRX, aiPLA2, p29 | peroxiredoxin 6 (EC:1.11.1.9 1.11.1.15) |
C00019560
|
| 5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00019560
|
| 5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00019560
|
| 5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00019560
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00019560
|
| 2185 | PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK | protein tyrosine kinase 2 beta (EC:2.7.10.2) |
C00019560
|
| 5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00019560
|
| 5884 | RAD17, CCYC, HRAD17, R24L, RAD17SP, RAD24 | RAD17 homolog (S. pombe) |
C00019560
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00019560
|
| 6236 | RRAD, RAD, RAD1, REM3 | Ras-related associated with diabetes |
C00019560
|
| 6275 | S100A4, 18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98 | S100 calcium binding protein A4 |
C00019560
|
| 6342 | SCP2, NLTP, NSL-TP, SCP-2, SCP-CHI, SCP-X, SCPX | sterol carrier protein 2 (EC:2.3.1.176) |
C00019560
|
| 23513 | SCRIB, CRIB1, SCRB1, SCRIB1, Vartul | scribbled planar cell polarity protein |
C00019560
|
| 6573 | SLC19A1, CHMD, FOLT, IFC1, REFC, RFC1 | solute carrier family 19 (folate transporter), member 1 |
C00019560
|
| 2030 | SLC29A1, ENT1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
C00019560
|
| 60682 | SMAP1, SMAP-1 | small ArfGAP 1 |
C00019560
|
| 6678 | SPARC, ON | secreted protein, acidic, cysteine-rich (osteonectin) |
C00019560
|
| 6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00019560
|
| 6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00019560
|
| 6723 | SRM, PAPT, SPDSY, SPS1, SRML1 | spermidine synthase (EC:2.5.1.16) |
C00019560
|
| 56910 | STARD7, GTT1 | StAR-related lipid transfer (START) domain containing 7 |
C00019560
|
| 6786 | STIM1, D11S4896E, GOK, IMD10, TAM | stromal interaction molecule 1 |
C00019560
|
| 3316 | HSPB2, HSP27, Hs.78846, LOH11CR1K, MKBP | heat shock 27kDa protein 2 |
C00003047
|
| 6783 | SULT1E1, EST, EST-1, ST1E1, STE | sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) |
C00019560
|
| 6822 | SULT2A1, DHEA-ST, DHEAS, HST, ST2, ST2A1, ST2A3, STD, hSTa | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 (EC:2.8.2.14) |
C00019560
|
| 9095 | TBX19, TBS19, TPIT, dJ747L4.1 | T-box 19 |
C00019560
|
| 7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00019560
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00019560
|
| 7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00019560
|
| 7082 | TJP1, ZO-1 | tight junction protein 1 |
C00019560
|
| 7083 | TK1, TK2 | thymidine kinase 1, soluble (EC:2.7.1.21) |
C00019560
|
| 7167 | TPI1, TIM, TPI, TPID | triosephosphate isomerase 1 (EC:5.3.1.1) |
C00019560
|
| 10107 | TRIM10, HERF1, RFB30, RNF9 | tripartite motif containing 10 |
C00019560
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00019560
|
| 7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00019560
|
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00019560
|
| 7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00019560
|
| 25925 | ZNF521, EHZF, Evi3 | zinc finger protein 521 |
C00019560
|
| 57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00048438
|
| 1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00048438
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00048438
|
| 1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00048438
|
| 1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00048438
|
| 2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00048438
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00048438
|
| 2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00048438
|
| 2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00048438
|
| 2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00048438
|
| 3033 | HADH, HAD, HADH1, HADHSC, HCDH, HHF4, MSCHAD, SCHAD | hydroxyacyl-CoA dehydrogenase (EC:1.1.1.35) |
C00048438
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00048438
|
| 4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00048438
|
| 4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00048438
|
| 1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00048438
|
| 5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00048438
|
| 22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00048438
|
| 140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00048438
|
| 7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00048438
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #218030 | Apparent mineralocorticoid excess; ame |
P80365
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
| #606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #301500 | Fabry disease |
P06280
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #143500 | Gilbert syndrome |
P22309
P22310 |
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #278300 | Xanthinuria, type i |
P47989
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00208 | Hyperbilirubinemia |
P22309
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D003877 | Dermatitis, Contact |
C00000805
C00000823 |
| D007674 | Kidney Diseases |
C00000823
C00048438 |
| D008107 | Liver Diseases |
C00000823
C00019560 |
| D008114 | Liver Neoplasms, Experimental |
C00000823
C00019560 |
| D008569 | Memory Disorders |
C00000823
C00019560 |
| D013276 | Stomach Ulcer |
C00000823
C00019560 |
| D012640 | Seizures |
C00048304
C00019560 |
| D056486 | Drug-Induced Liver Injury |
C00048304
C00019560 |
| D018805 | Sepsis |
C00019560
|
| D009369 | Neoplasms |
C00003047
|
| D003389 | Cranial Nerve Diseases |
C00048304
|
| D003556 | Cystitis |
C00048304
|
| D006937 | Hypercholesterolemia |
C00003047
|
| D007662 | Ketosis |
C00048304
|
| D009374 | Neoplasms, Experimental |
C00048304
|
| D017453 | Dermatitis, Irritant |
C00003047
|
| D012878 | Skin Neoplasms |
C00048304
|
| D014555 | Urination Disorders |
C00048304
|
| D000014 | Abnormalities, Drug-Induced |
C00019560
|
| D000138 | Acidosis |
C00019560
|
| D000140 | Acidosis, Lactic |
C00019560
|
| D058186 | Acute Kidney Injury |
C00019560
|
| D000402 | Airway Obstruction |
C00019560
|
| D000435 | Alcoholic Intoxication |
C00019560
|
| D020751 | Alcohol-Induced Disorders |
C00019560
|
| D020268 | Alcohol-Induced Disorders, Nervous System |
C00019560
|
| D000437 | Alcoholism |
C00019560
|
| D019973 | Alcohol-Related Disorders |
C00019560
|
| D020270 | Alcohol Withdrawal Seizures |
C00019560
|
| D000647 | Amnesia |
C00019560
|
| D020236 | Amnesia, Transient Global |
C00019560
|
| D019969 | Amphetamine-Related Disorders |
C00019560
|
| D000853 | Anophthalmos |
C00019560
|
| D000855 | Anorexia |
C00019560
|
| D001008 | Anxiety Disorders |
C00019560
|
| D001028 | Aortopulmonary Septal Defect |
C00019560
|
| D001247 | Asthenia |
C00019560
|
| D001259 | Ataxia |
C00019560
|
| D050197 | Atherosclerosis |
C00019560
|
| D054537 | Atrioventricular Block |
C00019560
|
| D001284 | Atrophy |
C00019560
|
| D001342 | Autonomic Nervous System Diseases |
C00019560
|
| D001714 | Bipolar Disorder |
C00019560
|
| D001766 | Blindness |
C00019560
|
| D001835 | Body Weight |
C00019560
|
| D001919 | Bradycardia |
C00019560
|
| D001927 | Brain Diseases |
C00019560
|
| D001929 | Brain Edema |
C00019560
|
| D001930 | Brain Injuries |
C00019560
|
| D002545 | Brain Ischemia |
C00019560
|
| D001986 | Bronchial Spasm |
C00019560
|
| D002056 | Burns |
C00019560
|
| D006528 | Carcinoma, Hepatocellular |
C00019560
|
| D006332 | Cardiomegaly |
C00019560
|
| D009202 | Cardiomyopathies |
C00019560
|
| D002310 | Cardiomyopathy, Alcoholic |
C00019560
|
| D002311 | Cardiomyopathy, Dilated |
C00019560
|
| D002318 | Cardiovascular Diseases |
C00019560
|
| D020215 | Carotid Artery, Internal, Dissection |
C00019560
|
| D002493 | Central Nervous System Diseases |
C00019560
|
| D002543 | Cerebral Hemorrhage |
C00019560
|
| D002779 | Cholestasis |
C00019560
|
| D002971 | Cleft Lip |
C00019560
|
| D002972 | Cleft Palate |
C00019560
|
| D019970 | Cocaine-Related Disorders |
C00019560
|
| D003072 | Cognition Disorders |
C00019560
|
| D003128 | COMA |
C00019560
|
| D003221 | Confusion |
C00019560
|
| C535464 | Conotruncal cardiac defects |
C00019560
|
| D003244 | Consciousness Disorders |
C00019560
|
| D019465 | Craniofacial Abnormalities |
C00019560
|
| D003645 | Death, Sudden |
C00019560
|
| D016757 | Death, Sudden, Cardiac |
C00019560
|
| D003693 | Delirium |
C00019560
|
| D003731 | Dental Caries |
C00019560
|
| D003866 | Depressive Disorder |
C00019560
|
| D003865 | Depressive Disorder, Major |
C00019560
|
| D002658 | Developmental Disabilities |
C00019560
|
| D004195 | Disease Models, Animal |
C00019560
|
| D018450 | Disease Progression |
C00019560
|
| D004244 | Dizziness |
C00019560
|
| D056487 | Drug-Induced Liver Injury, Chronic |
C00019560
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00019560
|
| D020820 | Dyskinesias |
C00019560
|
| D004417 | Dyspnea |
C00019560
|
| D004487 | Edema |
C00019560
|
| D004830 | Epilepsy, Tonic-Clonic |
C00019560
|
| D004938 | Esophageal Neoplasms |
C00019560
|
| D020329 | Essential Tremor |
C00019560
|
| D005234 | Fatty Liver |
C00019560
|
| D005235 | Fatty Liver, Alcoholic |
C00019560
|
| D063647 | Fetal Alcohol Spectrum Disorders |
C00019560
|
| D005313 | Fetal Death |
C00019560
|
| D005317 | Fetal Growth Retardation |
C00019560
|
| D005355 | Fibrosis |
C00019560
|
| D005483 | Flushing |
C00019560
|
| D005756 | Gastritis |
C00019560
|
| D005767 | Gastrointestinal Diseases |
C00019560
|
| D006130 | Growth Disorders |
C00019560
|
| D006212 | Hallucinations |
C00019560
|
| D006323 | Heart Arrest |
C00019560
|
| D006330 | Heart Defects, Congenital |
C00019560
|
| D006331 | Heart Diseases |
C00019560
|
| D006344 | Heart Septal Defects, Atrial |
C00019560
|
| D006345 | Heart Septal Defects, Ventricular |
C00019560
|
| D006470 | Hemorrhage |
C00019560
|
| D020141 | Hemostatic Disorders |
C00019560
|
| D006505 | Hepatitis |
C00019560
|
| D006519 | Hepatitis, Alcoholic |
C00019560
|
| D006529 | Hepatomegaly |
C00019560
|
| D006869 | Hydronephrosis |
C00019560
|
| D006930 | Hyperalgesia |
C00019560
|
| D006940 | Hyperemia |
C00019560
|
| D006945 | Hyperhidrosis |
C00019560
|
| D006948 | Hyperkinesis |
C00019560
|
| D006965 | Hyperplasia |
C00019560
|
| D006973 | Hypertension |
C00019560
|
| D015228 | Hypertriglyceridemia |
C00019560
|
| D017379 | Hypertrophy, Left Ventricular |
C00019560
|
| D007022 | Hypotension |
C00019560
|
| D007035 | Hypothermia |
C00019560
|
| D007154 | Immune System Diseases |
C00019560
|
| D007249 | Inflammation |
C00019560
|
| D008607 | Intellectual Disability |
C00019560
|
| D020300 | Intracranial Hemorrhages |
C00019560
|
| D007511 | Ischemia |
C00019560
|
| D007565 | Jaundice |
C00019560
|
| D007569 | Jaw Abnormalities |
C00019560
|
| D007683 | Kidney Tubular Necrosis, Acute |
C00019560
|
| D007859 | Learning Disorders |
C00019560
|
| D017880 | Limb Deformities, Congenital |
C00019560
|
| D008103 | Liver Cirrhosis |
C00019560
|
| D008104 | Liver Cirrhosis, Alcoholic |
C00019560
|
| D008106 | Liver Cirrhosis, Experimental |
C00019560
|
| D008108 | Liver Diseases, Alcoholic |
C00019560
|
| D017114 | Liver Failure, Acute |
C00019560
|
| D008133 | Long QT Syndrome |
C00019560
|
| D008175 | Lung Neoplasms |
C00019560
|
| D008831 | Microcephaly |
C00019560
|
| D048629 | Micronuclei, Chromosome-Defective |
C00019560
|
| D008850 | Microphthalmos |
C00019560
|
| D009059 | Mouth Diseases |
C00019560
|
| D009069 | Movement Disorders |
C00019560
|
| D009135 | Muscular Diseases |
C00019560
|
| D009203 | Myocardial Infarction |
C00019560
|
| D017202 | Myocardial Ischemia |
C00019560
|
| D009325 | Nausea |
C00019560
|
| D009336 | Necrosis |
C00019560
|
| D009361 | Neoplasm Invasiveness |
C00019560
|
| D009362 | Neoplasm Metastasis |
C00019560
|
| D009422 | Nervous System Diseases |
C00019560
|
| D051474 | Neuralgia, Postherpetic |
C00019560
|
| D009436 | Neural Tube Defects |
C00019560
|
| D019954 | Neurobehavioral Manifestations |
C00019560
|
| D020258 | Neurotoxicity Syndromes |
C00019560
|
| D009901 | Optic Nerve Diseases |
C00019560
|
| D010146 | Pain |
C00019560
|
| D010190 | Pancreatic Neoplasms |
C00019560
|
| D010195 | Pancreatitis |
C00019560
|
| D019512 | Pancreatitis, Alcoholic |
C00019560
|
| D010243 | Paralysis |
C00019560
|
| D010523 | Peripheral Nervous System Diseases |
C00019560
|
| D010538 | Peritonitis |
C00019560
|
| D010698 | Phobic Disorders |
C00019560
|
| D011041 | Poisoning |
C00019560
|
| D011115 | Polyneuropathies |
C00019560
|
| D017119 | Porphyria Cutanea Tarda |
C00019560
|
| D011297 | Prenatal Exposure Delayed Effects |
C00019560
|
| D049188 | Prenatal Injuries |
C00019560
|
| D015175 | Prolactinoma |
C00019560
|
| D011507 | Proteinuria |
C00019560
|
| D011596 | Psychomotor Disorders |
C00019560
|
| D011605 | Psychoses, Substance-Induced |
C00019560
|
| D011654 | Pulmonary Edema |
C00019560
|
| D015427 | Reperfusion Injury |
C00019560
|
| D012141 | Respiratory Tract Infections |
C00019560
|
| D012164 | Retinal Diseases |
C00019560
|
| D012206 | Rhabdomyolysis |
C00019560
|
| D007938 | Leukemia |
C00003047
|
| D020018 | Sexual Dysfunctions, Psychological |
C00019560
|
| D013272 | Stomach Diseases |
C00019560
|
| D013274 | Stomach Neoplasms |
C00019560
|
| D020521 | Stroke |
C00019560
|
| D053608 | Stupor |
C00019560
|
| D013345 | Subarachnoid Hemorrhage |
C00019560
|
| D019966 | Substance-Related Disorders |
C00019560
|
| D013375 | Substance Withdrawal Syndrome |
C00019560
|
| D013610 | Tachycardia |
C00019560
|
| D017180 | Tachycardia, Ventricular |
C00019560
|
| D013683 | Telangiectasia, Hereditary Hemorrhagic |
C00019560
|
| D013771 | Tetralogy of Fallot |
C00019560
|
| D018677 | Tooth Injuries |
C00019560
|
| D016388 | Tooth Loss |
C00019560
|
| D016171 | Torsades de Pointes |
C00019560
|
| D014202 | Tremor |
C00019560
|
| D014474 | Unconsciousness |
C00019560
|
| D016055 | Urinary Retention |
C00019560
|
| D054079 | Vascular Malformations |
C00019560
|
| D018487 | Ventricular Dysfunction, Left |
C00019560
|
| D014693 | Ventricular Fibrillation |
C00019560
|
| D018879 | Ventricular Premature Complexes |
C00019560
|
| D014811 | Vitamin E Deficiency |
C00019560
|
| D014839 | Vomiting |
C00019560
|
| D015430 | Weight Gain |
C00019560
|
| D015431 | Weight Loss |
C00019560
|
| D012772 | Shock, Septic |
C00048438
|